Léčivý přípravek s obsahem účinné látky FARICIMAB

TENDER DESCRIPTION

The subject matter of this public contract is the continuous supply of a medicinal product containing the active substance faricimab (ATC S01LA09) for the treatment of patients in the approved indications in accordance with the SPC valid as of the date of submission of tenders, to the extent required by the contracting authority. The aim of the contracting authority is to ensure, for its activities, the continuous supply of medicinal products for the treatment of patients for a period of 1 year from the date the framework purchase contract becomes effective. The subject matter of this public contract is the continuous supply of a medicinal product containing the active substance faricimab (ATC S01LA09) for the treatment of patients in the approved indications in accordance with the SPC valid as of the date of submission of tenders, to the extent required by the contracting authority. The aim of the contracting authority is to ensure, for its activities, the continuous supply of medicinal products for the treatment of patients for a period of 1 year from the date the framework purchase contract becomes effective.

TENDER BRIEF

TENDER DOCUMENTS